fotemustine has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aapro, MS; Beex, LV; Guastalla, JP; Kobierska, A; Namer, M; Rosso, R; Splinter, TE; ten Bokkel Huinink, W; van der Burg, ME; van Wijk, FH; Vergote, I; Vermorken, JB | 1 |
| Breen, M; Brownsill, R; Gordon, BH; Gray, AJ; Hiley, M; Ings, RM; Marchant, N; Richards, R; Taylor, AR; Wallace, D | 1 |
1 trial(s) available for fotemustine and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.
Topics: Adult; Aged; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Middle Aged; Nausea; Nitrosourea Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Vomiting | 2003 |
1 other study(ies) available for fotemustine and Ovarian Neoplasms
| Article | Year |
|---|---|
Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
Topics: Aged; Antineoplastic Agents; Carbon Radioisotopes; Ethylene Chlorohydrin; Feces; Female; Half-Life; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Time Factors | 1990 |